Cargando…

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition

An important aspect of modern medicine is its orientation to achieve more personalized pharmacological treatments. In this context, transporters involved in drug disposition have gained well-justified attention. Owing to its broad spectrum of substrate specificity, including endogenous compounds and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lozano, Elisa, Briz, Oscar, Macias, Rocio I. R., Serrano, Maria A., Marin, Jose J. G., Herraez, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023491/ https://www.ncbi.nlm.nih.gov/pubmed/29659532 http://dx.doi.org/10.3390/jpm8020014

Ejemplares similares

Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1
por: Herraez, Elisa, et al.
Publicado: (2017)

Models for Understanding Resistance to Chemotherapy in Liver Cancer
por: Marin, Jose J. G., et al.
Publicado: (2019)

Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
por: Macias, Rocio I.R., et al.
Publicado: (2018)

Role of the Plasma Membrane Transporter of Organic Cations OCT1 and Its Genetic Variants in Modern Liver Pharmacology
por: Lozano, Elisa, et al.
Publicado: (2013)

Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020)

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
por: Marin, Jose J. G., et al.
Publicado: (2019)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
por: Rodríguez-Macías, Gabriela, et al.
Publicado: (2023)

Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma
por: Marin, Jose J. G., et al.
Publicado: (2020)

The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
por: Marin, Jose JG, et al.
Publicado: (2014)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition
por: Zazuli, Zulfan, et al.
Publicado: (2020)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015)

Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment
por: Marin, Jose J.G., et al.
Publicado: (2020)

Genetic and Epigenetic Regulation of the Organic Cation Transporter 3, SLC22A3
por: Chen, Ligong, et al.
Publicado: (2012)

Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
por: Mooij, Miriam G., et al.
Publicado: (2015)

Role of Genetic Variations in the Hepatic Handling of Drugs
por: Marin, Jose J. G., et al.
Publicado: (2020)

Interactions of 172 plant extracts with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8): a study on herb-drug interactions
por: Lu, Hang, et al.
Publicado: (2017)

Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
por: Wang, Li, et al.
Publicado: (2013)

Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs
por: Lai, Raymond E., et al.
Publicado: (2018)

Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
por: Whisenant, Thomas C., et al.
Publicado: (2022)

Induction of Drug Transporters Alters Disposition of Risperidone - A Study in Mice
por: Holthoewer, David, et al.
Publicado: (2010)

Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition
por: Parvez, Md Masud, et al.
Publicado: (2023)

Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
por: Lozano, Elisa, et al.
Publicado: (2023)

The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics
por: Yee, Sook Wah, et al.
Publicado: (2023)

Morphine metabolism, transport and brain disposition
por: De Gregori, Simona, et al.
Publicado: (2011)

Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
por: Console, Lara, et al.
Publicado: (2018)

Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography
por: Hernández Lozano, Irene, et al.
Publicado: (2019)

Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
por: Marin, Jose J. G., et al.
Publicado: (2022)

The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2
por: Enogieru, Osatohanmwen J., et al.
Publicado: (2021)

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
por: Heise, Michael, et al.
Publicado: (2012)

Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism
por: Gan, Changpei, et al.
Publicado: (2023)

Structural basis for amino acid transport by the CAT family of SLC7 transporters
por: Jungnickel, Katharina E. J., et al.
Publicado: (2018)

Introduction of Organic Anion Transporters (SLC22A) and a Regulatory Mechanism by Caveolins
por: Lee, Woon Kyu, et al.
Publicado: (2006)

Effect of Cholesterol on the Organic Cation Transporter OCTN1 (SLC22A4)
por: Pochini, Lorena, et al.
Publicado: (2020)

SLC22 Transporters in the Fly Renal System Regulate Response to Oxidative Stress In Vivo
por: Zhang, Patrick, et al.
Publicado: (2021)

Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
por: Yee, Sook Wah, et al.
Publicado: (2023)

Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
por: Yee, Sook Wah, et al.
Publicado: (2023)

Nucleotide Sugar Transporter SLC35 Family Structure and Function
por: Hadley, Barbara, et al.
Publicado: (2019)

Sex Differences in Drug Disposition
por: Soldin, Offie P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lnp5afim3vjkl9j3fu7rqcp7ud